BridgeMD
New treatment option for Primary Progressive Aphasia
Official title Semantic Rehabilitation for Patients With Primary Progressive Semantic Aphasia
ClinicalTrials.gov ID: NCT04957537
What this study is testing
- What it's testing
- This project aims to measure the effect of a semantic rehabilitation protocol for patients with primary progressive semantic aphasia and using the SCED methodology.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 100
You may be able to join if
- Have a diagnosis of primary progressive semantic aphasia according to the criteria of Gorno-Tempini et al (2011) (Appendix A)
- Being in the mild to moderate stage of dementia (MMSE score between 10 and 28) (Crum et al., 1993; Derouesné et al., 1999)
- Common French
- Being affiliated to a social security scheme
- Being over the age of 18 years old
You likely can't join if
- Have significant uncorrected visual and/or hearing impairment
- Have a history of brain injuries, major head trauma
- Have untreated psychiatric disorders
- Have significant motor and/or comprehension problems that make it impossible to take part in the study
- Chronical use of drugs and/or alcohol
- Under guardians or curators
See the full eligibility criteria
- Have a diagnosis of primary progressive semantic aphasia according to the criteria of Gorno-Tempini et al (2011) (Appendix A)
- Being in the mild to moderate stage of dementia (MMSE score between 10 and 28) (Crum et al., 1993; Derouesné et al., 1999)
- Common French
- Being affiliated to a social security scheme
- Being over the age of 18 years old
- Have significant uncorrected visual and/or hearing impairment
- Have a history of brain injuries, major head trauma
- Have untreated psychiatric disorders
- Have significant motor and/or comprehension problems that make it impossible to take part in the study
- Chronical use of drugs and/or alcohol
- Under guardians or curators
- Severe depression (Beck's depression scale score \> 9) (Beck \& al., 1961)
The study team makes the final eligibility decision.
Where it's taking place
- Toulouse, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 100 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Toulouse, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.